Arrowhead Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US04280A1007

SecurityARWR / Arrowhead Pharmaceuticals, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership251,568 shares
Latest Disclosed Value $ 15,773,313
Citigroup Inc ownership in ARWR / Arrowhead Pharmaceuticals, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 251,568 shares of Arrowhead Pharmaceuticals, Inc. (US:ARWR) valued at $15,773,314 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 42,743 shares of Arrowhead Pharmaceuticals, Inc.. This represents a change in shares of 488.56% during the quarter. The current value of the position is $18,251,258 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (ARWR) in the form of stock options. The firm currently holds call options representing 20,500 of underlying shares valued at $1,285,350 USD and put options representing 20,500 of underlying shares valued at $1,285,350 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ARWR / Arrowhead Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 251,568 208,825 488.56 15,773 455.97 0.0034
2026-02-13 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 42,743 -8,839 -17.14 2,838 59.47 0.0013
2025-11-10 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 51,582 -89,204 -63.36 1,779 -20.01 0.0008
2025-08-11 2025-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 140,786 -186,524 -56.99 2,224 -46.65 0.0011
2025-05-12 2025-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 327,310 153,402 88.21 4,170 27.53 0.0021
2025-02-12 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 173,908 75,840 77.33 3,269 72.14 0.0019
2024-11-12 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 98,068 -139,948 -58.80 1,900 -69.30 0.0011
2024-08-12 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 238,016 -42,968 -15.29 6,186 -23.02 0.0040
2024-05-10 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 280,984 94,042 50.31 8,036 40.49 0.0053
2024-02-09 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 186,942 25,144 15.54 5,720 31.59 0.0040
2023-12-06 2023-09-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 161,798 59,279 57.82 4,348 18.93 0.0032
2023-11-09 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 161,798 59,279 4,348 0.0013
2023-08-10 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 102,519 -130,389 -55.98 3,656 -38.21 0.0024
2023-05-11 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 232,908 95,568 69.58 5,916 6.19 0.0041
2023-02-09 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 137,340 -75,411 -35.45 5,571 -20.78 0.0044
2022-11-10 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 212,751 67,631 46.60 7,031 37.62 0.0050
2022-08-10 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 145,120 105,843 269.48 5,109 182.73 0.0038
2022-05-12 2022-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 39,277 -60,765 -60.74 1,807 -72.76 0.0011
2022-02-10 2021-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 100,042 15,554 18.41 6,633 25.74 0.0036
2021-11-10 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 84,488 -20,115 -19.23 5,275 -39.12 0.0031
2021-08-10 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 104,603 6,732 6.88 8,664 33.50 0.0052
2021-05-13 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 97,871 -35,573 -26.66 6,490 -36.61 0.0042
2021-02-11 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 133,444 45,007 50.89 10,239 168.81 0.0060
2020-11-12 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 88,437 -27,091 -23.45 3,809 -23.67 0.0025
2020-08-12 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 115,528 -12,309 -9.63 4,990 35.63 0.0039
2020-05-12 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 127,837 65,070 103.67 3,679 -7.59 0.0033
2020-02-12 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 62,767 -82,056 -56.66 3,981 -2.47 0.0029
2019-11-08 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 144,823 -114,338 -44.12 4,082 -40.56 0.0032
2019-08-12 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 259,161 109,923 73.66 6,868 150.84 0.0055
2019-05-13 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 149,238 -545,663 -78.52 2,738 -68.28 0.0026
2019-02-12 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 694,901 468,673 207.17 8,631 99.05 0.0087
2018-11-13 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 226,228 97,328 75.51 4,336 147.35 0.0039
2018-08-10 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 128,900 6,436 5.26 1,753 98.53 0.0016
2018-05-11 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 122,464 120,003 4,876.19 883 9,711.11 0.0007
2018-02-12 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 2,461 -726 -22.78 9 -35.71 0.0000
2017-11-13 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 3,187 -5,359 -62.71 14 0.00 0.0000
2017-08-11 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 8,546 -10,683 -55.56 14 -60.00 0.0000
2017-05-12 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 19,229 -62,434 -76.45 35 -72.44 0.0000
2017-02-10 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 81,663 78,863 2,816.54 127 504.76 0.0001
2016-11-10 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 2,800 -3,655 -56.62 21 -40.00 0.0000
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 6,455 6,455 35 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 20,500 1,285 n/a n/a n/a
2024-11-12 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 46,100 85.14 1,198 68.26 n/a n/a n/a
2024-05-10 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 24,900 39.89 712 30.88 n/a n/a n/a
2024-02-09 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 17,800 545 n/a n/a n/a
2023-12-06 2023-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-09 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 0 0 n/a n/a n/a
2023-08-10 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 54,900 -8.19 1,958 28.92 n/a n/a n/a
2023-05-11 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 59,800 24.58 1,519 -21.99 n/a n/a n/a
2023-02-09 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 48,000 60.00 1,947 96.17 n/a n/a n/a
2022-11-10 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 30,000 0.00 992 -6.06 n/a n/a n/a
2022-08-10 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 30,000 1,056 n/a n/a n/a
2021-05-13 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 122,800 95.23 9,422 247.93 n/a n/a n/a
2020-11-12 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 62,900 11.33 2,708 10.98 n/a n/a n/a
2020-08-12 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 56,500 55.65 2,440 133.72 n/a n/a n/a
2020-05-12 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 36,300 -41.17 1,044 -73.33 n/a n/a n/a
2020-02-12 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 61,700 86.40 3,914 319.51 n/a n/a n/a
2019-11-08 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 33,100 -7.28 933 -1.37 n/a n/a n/a
2019-08-12 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 35,700 25.26 946 80.88 n/a n/a n/a
2019-05-13 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 28,500 -20.83 523 17.00 n/a n/a n/a
2019-02-12 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 36,000 -20.88 447 -48.74 n/a n/a n/a
2018-11-13 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 45,500 49.18 872 110.12 n/a n/a n/a
2018-08-10 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 30,500 132.82 415 341.49 n/a n/a n/a
2018-05-11 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 13,100 -30.32 94 36.23 n/a n/a n/a
2018-02-12 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 18,800 -40.13 69 -49.26 n/a n/a n/a
2017-11-13 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 31,400 1,265.22 136 3,300.00 n/a n/a n/a
2017-08-11 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 2,300 9.52 4 0.00 n/a n/a n/a
2017-05-12 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 2,100 -82.79 4 -78.95 n/a n/a n/a
2017-02-10 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 12,200 -36.46 19 -86.52 n/a n/a n/a
2016-11-10 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 19,200 772.73 141 1,075.00 n/a n/a n/a
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 2,200 12 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 20,500 1,285 n/a n/a n/a
2024-11-12 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 46,100 85.14 1,198 68.26 n/a n/a n/a
2024-05-10 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 24,900 39.89 712 30.88 n/a n/a n/a
2024-02-09 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 17,800 545 n/a n/a n/a
2023-12-06 2023-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-09 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 0 0 n/a n/a n/a
2023-08-10 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 54,900 -8.19 1,958 28.92 n/a n/a n/a
2023-05-11 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 59,800 24.58 1,519 -21.99 n/a n/a n/a
2023-02-09 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 48,000 60.00 1,947 96.17 n/a n/a n/a
2022-11-10 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 30,000 0.00 992 -6.06 n/a n/a n/a
2022-08-10 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 30,000 1,056 n/a n/a n/a
2021-05-13 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 65,500 -0.61 5,026 77.10 n/a n/a n/a
2020-11-12 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 65,900 14.81 2,838 14.48 n/a n/a n/a
2020-08-12 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 57,400 19.33 2,479 79.12 n/a n/a n/a
2020-05-12 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 48,100 147.94 1,384 12.43 n/a n/a n/a
2020-02-12 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 19,400 46.97 1,231 230.91 n/a n/a n/a
2019-11-08 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 13,200 26.92 372 34.78 n/a n/a n/a
2019-08-12 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 10,400 85.71 276 167.96 n/a n/a n/a
2019-05-13 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 5,600 -82.45 103 -73.99 n/a n/a n/a
2019-02-12 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 31,900 -33.68 396 -57.05 n/a n/a n/a
2018-11-13 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 48,100 70.57 922 140.10 n/a n/a n/a
2018-08-10 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 28,200 79.62 384 239.82 n/a n/a n/a
2018-05-11 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 15,700 134.33 113 352.00 n/a n/a n/a
2018-02-12 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 6,700 25 n/a n/a n/a
2017-08-11 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-12 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 7,000 66.67 13 85.71 n/a n/a n/a
2017-02-10 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 4,200 -49.40 7 -88.52 n/a n/a n/a
2016-11-10 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 8,300 61 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.